Macfarlane Burnet Institute for Medical Research and Public Health Ltd
16
0
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
19%
3 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
The Optimising Isolation, Quarantine and Distancing Study for COVID-19
Role: lead
Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea
Role: lead
Comparing a Novel Point-of-care Cytokine Biomarker Lateral Flow Test With Nucleic Acid Amplification Tests for Detection of Sexually Transmitted Infections and Bacterial Vaginosis
Role: collaborator
Same-visit Hepatitis C Testing and Treatment (The QuickStart Study)
Role: lead
Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%
Role: lead
The Optimising Isolation, Quarantine and Distancing Study for COVID-19 (Optimise)
Role: lead
Link Hepatitis C Notifications to Treatment in Tasmania
Role: lead
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia
Role: lead
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar
Role: lead
Eliminate Hepatitis C/EC Partnership Evaluation Protocol
Role: lead
Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)
Role: lead
Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar
Role: lead
Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals
Role: lead
Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study
Role: lead
The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital
Role: lead
The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach
Role: lead
All 16 trials loaded